tiprankstipranks
Alibaba Health Information Technology Ltd. (HK:0241)
:0241
Hong Kong Market

Alibaba Health Information Technology (0241) Financial Statements

Compare
9 Followers

Alibaba Health Information Technology Financial Overview

Alibaba Health Information Technology's market cap is currently $92.66B. The company's EPS TTM is HK$0.084; its P/E ratio is 68.33; Alibaba Health Information Technology is scheduled to report earnings on May 27, 2025, and the estimated EPS forecast is HK$0.08. See an overview of income statement, balance sheet, and cash flow financials.
Mar 24Mar 23Mar 22Mar 21Mar 20
Income Statement
Total Revenue¥ 27.03B¥ 26.76B¥ 20.58B¥ 15.52B¥ 9.60B
Gross Profit¥ 5.90B¥ 5.70B¥ 4.11B¥ 3.62B¥ 2.23B
Operating Income¥ 872.40M¥ -51.50M¥ -1.10B¥ 37.47M¥ -67.42M
EBITDA¥ 999.05M¥ -24.48M¥ -188.12M¥ 52.14M¥ -53.03M
Net Income¥ 883.48M¥ 535.65M¥ -265.56M¥ 348.59M¥ -6.59M
Balance Sheet
Cash & Short-Term Investments¥ 9.55B¥ 10.92B¥ 10.55B¥ 11.64B¥ 3.00B
Total Assets¥ 19.71B¥ 20.75B¥ 19.20B¥ 17.74B¥ 7.87B
Total Debt¥ 82.17M¥ 77.80M¥ 135.41M¥ 37.74M¥ 69.75M
Net Debt¥ -9.47B¥ -10.84B¥ -10.41B¥ -11.60B¥ -2.53B
Total Liabilities¥ 5.19B¥ 5.60B¥ 5.13B¥ 3.46B¥ 2.67B
Stockholders' Equity¥ 14.54B¥ 15.17B¥ 14.10B¥ 14.30B¥ 5.27B
Cash Flow
Free Cash Flow¥ 1.06B¥ 250.08M¥ 409.43M¥ 992.35M¥ 576.05M
Operating Cash Flow¥ 1.08B¥ 255.69M¥ 424.36M¥ 1.01B¥ 583.62M
Investing Cash Flow¥ -4.88B¥ -532.44M¥ 1.87B¥ -4.96B¥ 1.35B
Financing Cash Flow¥ -1.98B¥ -111.28M¥ -58.63M¥ 8.92B¥ 328.81M
Currency in CNY

Alibaba Health Information Technology Earnings and Revenue History

Alibaba Health Information Technology Debt to Assets

Alibaba Health Information Technology Cash Flow

Alibaba Health Information Technology Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis